Skip to content

Term

Luteal phase dosing: what it means for PMDD

Luteal phase dosing means taking an SSRI only during the luteal phase, the one to two weeks before your period, instead of every day of the cycle. Doctors have studied this timing specifically for PMDD, since its symptoms cluster in that window. Several randomized trials found it reduces symptoms more than placebo, though a doctor decides if it fits you.

Updated Niyora editorial Strong evidence

At a glance

  • Luteal phase dosing means taking an SSRI only in the one to two weeks before your period, not every day of the cycle.
  • Randomized trials on fluoxetine, paroxetine CR, escitalopram, sertraline and citalopram all found luteal phase dosing reduced PMDD symptoms more than placebo.
  • One trial found escitalopram worked about as well starting at symptom onset as it did dosed through the whole luteal phase.
  • Stopping and restarting an SSRI each cycle wasn't linked to significant withdrawal symptoms in one review of sertraline trials.
  • A doctor decides the drug, dose and timing pattern that fits your symptoms and cycle.

Strength of evidence

Strong evidence

Multiple randomized, placebo-controlled trials across SSRIs found luteal phase dosing reduced PMDD symptoms more than placebo ([1], [2], [5], [7]), and a head-to-head trial and a review found symptom-onset dosing worked about as well in some women ([3], [6]). One sertraline review found no significant discontinuation effects ( [4]).

What is luteal phase dosing for SSRIs?

Luteal phase dosing means taking a medication, usually an SSRI, only in the luteal phase, the one to two weeks between ovulation and your period, rather than every day of the cycle.

For PMDD, that usually means following three steps:

  • Start the SSRI around ovulation
  • Stop it once bleeding begins
  • Restart it the next cycle

Some trials used a single higher dose timed to the late luteal phase instead of a daily routine ( [1]).

The two main dosing patterns studied for PMDD are:

  • Luteal phase dosing: taking the SSRI only in the one to two weeks before the period
  • Continuous dosing: taking the same medication every day, all month, whether or not symptoms are active

How does luteal phase dosing relate to PMS and PMDD?

PMDD symptoms follow the luteal phase by definition: they show up in the final week before a period, ease within a few days of bleeding starting, and leave a mostly symptom-free week after (PMDD). PMS follows a similar but usually milder pattern.

Because PMDD symptoms cluster in part of the cycle, some SSRIs can work when taken only in that window instead of daily. Knowing where you are in your cycle helps you and a doctor see whether luteal phase dosing fits your pattern.

If a mood problem is present all month and just gets worse before your period, that's premenstrual exacerbation, not PMDD, and continuous dosing usually fits better.

What does the research say about luteal phase dosing?

Luteal phase dosing has been tested against placebo in several randomized, double-blind trials, mostly with SSRIs.

SSRI Luteal-phase pattern studied What the trial found
Fluoxetine 90 mg, twice in the luteal phase Significant improvement in mood and functioning scores versus placebo in the twice-dosed group ( [1])
Paroxetine CR 12.5 mg or 25 mg daily, luteal phase only Both doses beat placebo on mood and functional measures ( [2])
Escitalopram 10 to 20 mg/day, luteal phase versus symptom-onset Symptom scores fell 57% with luteal dosing, 51% with symptom-onset dosing ( [3])
Sertraline 50 to 100 mg/day, luteal phase only 50% of women responded versus 26% on placebo ( [7])
Citalopram 20 mg/day, luteal phase only Intermittent luteal dosing seemed to work better than continuous or semi-intermittent dosing ( [5])

A 2013 review of this body of evidence found that for some women, starting an SSRI only when symptoms begin works about as well as dosing through the whole luteal phase ( [6]). See the wider research on PMS and PMDD for more on how these trials were designed.

Why does luteal phase dosing matter, and what terms go with it?

Luteal phase dosing can mean fewer days on medication each month than continuous dosing, which may lower cost and side effects ( [4]). It also means remembering doses for roughly two weeks of the cycle rather than all month, though that takes a fairly predictable cycle to time well.

If you want somewhere to put what's happening while you and a doctor work out a plan, Niyora is a PMS and PMDD support app. It gives you an estimated PMS window, so you can see roughly when the luteal phase is starting while you work that out.

A few related terms worth knowing:

From the research library

Research on SSRIs

528 studies in the library look at SSRIs in PMS and PMDD. They were published from 1971 to 2026, and each one has a short summary of what was tested and found.

528

studies, 1971 to 2026

How strong the studies are

Strong study design
102
Moderate study design
156
Early or limited evidence
270

See all 528 studies on SSRIs and antidepressants

Questions people ask

What is luteal phase dosing?+

Luteal phase dosing means taking a medication, almost always an SSRI, only during the luteal phase, the one to two weeks before a period, instead of every day of the cycle. Doctors have studied this pattern specifically for PMDD, since its symptoms are limited to that window.

Does luteal phase dosing work as well as daily dosing?+

In a trial comparing escitalopram given through the luteal phase against escitalopram started only at symptom onset, both patterns cut symptom scores by about half, with luteal dosing slightly ahead at 57% versus 51% ( [3]). A doctor helps choose based on how predictable your symptoms are.

Which SSRIs have been studied for luteal phase dosing?+

Luteal phase dosing has been studied with fluoxetine, paroxetine CR, sertraline, escitalopram and citalopram, each tested against placebo in randomized trials ( [1], [2], [3], [5], [7]). A doctor decides which drug and schedule fits your symptoms and cycle.

Does stopping and restarting an SSRI each cycle cause withdrawal?+

One review of sertraline trials found that despite repeated cyclical stopping and restarting, luteal phase dosing wasn't linked to significant discontinuation symptoms ( [4]). Response varies by person, so a doctor monitors you across a few cycles before settling on a long-term pattern.

Who decides if luteal phase dosing is right for me?+

A GP or gynecologist decides whether luteal phase dosing fits you, based on your symptom pattern, history and how regular your cycle is. Bringing two or more cycles of daily symptom notes helps them see whether your symptoms are confined to the luteal phase.

Sources

  1. 1.Weekly luteal-phase dosing with enteric-coated fluoxetine 90 mg in premenstrual dysphoric disorder: a randomized, double-blind, placebo-controlled clinical trial, Clinical therapeutics, 2002
  2. 2.Luteal phase dosing with paroxetine controlled release (CR) in the treatment of premenstrual dysphoric disorder, American journal of obstetrics and gynecology, 2005
  3. 3.A preliminary study of luteal phase versus symptom-onset dosing with escitalopram for premenstrual dysphoric disorder, The Journal of clinical psychiatry, 2005
  4. 4.Treatment of premenstrual dysphoric disorder with luteal phase dosing of sertraline, Expert opinion on pharmacotherapy, 2003
  5. 5.Citalopram in premenstrual dysphoria: is intermittent treatment during luteal phases more effective than continuous medication throughout the menstrual cycle?, Journal of clinical psychopharmacology, 1998
  6. 6.Luteal phase and symptom-onset dosing of SSRIs/SNRIs in the treatment of premenstrual dysphoria: clinical evidence and rationale, CNS drugs, 2013
  7. 7.Efficacy of intermittent, luteal phase sertraline treatment of premenstrual dysphoric disorder, Obstetrics and gynecology, 2002